Long‐term prognosis in patients with non‐type 1 Brugada electrocardiogram: Results from a large Japanese cohort of idiopathic ventricular fibrillation

• Published in: Annals of noninvasive electrocardiology Vol. 26; no. 4; pp. e12831 - n/a
• Main Authors: Shinohara, Tetsuji, Takagi, Masahiko, Kamakura, Tsukasa, Sekiguchi, Yukio, Yokoyama, Yasuhiro, Aihara, Naohiko, Hiraoka, Masayasu, Aonuma, Kazutaka
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.07.2021; John Wiley and Sons Inc; Wiley
• Subjects: Brugada syndrome; Cardiac arrest; Cardiac arrhythmia; EKG; Electrical stimuli; Electrocardiography; Fever; Fibrillation; Heart; Medical prognosis; Morphology; Original; Patients; Prognosis; Risk analysis; Risk factors; Statistical analysis; sudden death; Survival analysis; Syncope; Ventricle; Ventricular fibrillation; Brugada syndrome; sudden death; cardiac arrest
• ISSN: 1082-720X; 1542-474X
• DOI: 10.1111/anec.12831

Background Brugada syndrome (BrS) is diagnosed in patients with ST‐segment elevation with spontaneous, drug‐induced, or fever‐induced type 1 morphology. Prognosis in type 2 or 3 Brugada electrocardiogram (Br‐ECG) patients remains unknown. The purpose of this study is to evaluate long‐term prognosis in non‐type 1 Br‐ECG patients in a large Japanese cohort of idiopathic ventricular fibrillation (The Japan Idiopathic Ventricular Fibrillation Study [J‐IVFS]). Methods From 567 patients with Br‐ECG in J‐IVFS, a total of 28 consecutive non‐type 1 patients who underwent programmed electrical stimulation (PES) (median age: 58 years, all male, previous sustained ventricular tachyarrhythmias [VTs] 1, syncope 11, asymptomatic 16) were enrolled. Cardiac events (CEs: sudden cardiac death or sustained VT/ventricular fibrillation) during the follow‐up period were examined. Results During a median follow‐up of 136 months, four patients (14%) had CEs. None of patients with PES‐ have experienced CEs. There was no statistically significant clinical risk factor for the development of CEs. Using the Kaplan–Meier method, the event‐free rate significantly decreased in a group with all 3 risk factors (symptom, wide QRS complex in lead V2, and positive PES) (p = .01). Conclusions Our study revealed long‐term prognosis in patients with non‐type 1 Br‐ECG. The combination analysis of these risk factors may be useful for the risk stratification of CEs in non‐type 1 Br‐ECG patients. The present study suggests that the patients with all these parameters showed high risk for CEs and need to be carefully followed.